These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10676661)

  • 1. Basic fibroblast growth factor confers a less malignant phenotype in MDA-MB-231 human breast cancer cells.
    Korah RM; Sysounthone V; Golowa Y; Wieder R
    Cancer Res; 2000 Feb; 60(3):733-40. PubMed ID: 10676661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells.
    Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL
    Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular FGF-2 promotes differentiation in T-47D breast cancer cells.
    Korah RM; Sysounthone V; Scheff E; Wieder R
    Biochem Biophys Res Commun; 2000 Oct; 277(1):255-60. PubMed ID: 11027671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
    Lin Y; Wang SM; Huang RP
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
    Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
    Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium.
    Korah R; Das K; Lindy ME; Hameed M; Wieder R
    Hum Pathol; 2007 Jan; 38(1):154-60. PubMed ID: 16996573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands.
    McLeskey SW; Ding IY; Lippman ME; Kern FG
    Cancer Res; 1994 Jan; 54(2):523-30. PubMed ID: 7506125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF-8b increases angiogenic capacity and tumor growth of androgen-regulated S115 breast cancer cells.
    Mattila MM; Ruohola JK; Valve EM; Tasanen MJ; Seppänen JA; Härkönen PL
    Oncogene; 2001 May; 20(22):2791-804. PubMed ID: 11420691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of FGF-2 alters focal adhesion dynamics in migration-restricted MDA-MB-231 breast cancer cells.
    Korah R; Choi L; Barrios J; Wieder R
    Breast Cancer Res Treat; 2004 Nov; 88(1):17-28. PubMed ID: 15538042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor.
    Wellstein A; Lupu R; Zugmaier G; Flamm SL; Cheville AL; Delli Bovi P; Basilico C; Lippman ME; Kern FG
    Cell Growth Differ; 1990 Feb; 1(2):63-71. PubMed ID: 1964794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
    Jones JL; Shaw JA; Pringle JH; Walker RA
    J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular role for lysyl oxidase in breast cancer invasion.
    Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ
    Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor.
    Sapi E; Flick MB; Rodov S; Gilmore-Hebert M; Kelley M; Rockwell S; Kacinski BM
    Cancer Res; 1996 Dec; 56(24):5704-12. PubMed ID: 8971179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice.
    Zhang L; Kharbanda S; Chen D; Bullocks J; Miller DL; Ding IY; Hanfelt J; McLeskey SW; Kern FG
    Oncogene; 1997 Oct; 15(17):2093-108. PubMed ID: 9366526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between LKB1 gene and invasion-related factors of breast cancer cells].
    Zhuang ZG; Di GH; Hou YF; Liu G; Luo JM; Shen ZZ; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):81-4. PubMed ID: 17418010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
    Delehedde M; Deudon E; Boilly B; Hondermarck H
    Exp Cell Res; 1996 Dec; 229(2):398-406. PubMed ID: 8986623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
    Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
    Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins.
    Sumida T; Itahana Y; Hamakawa H; Desprez PY
    Cancer Res; 2004 Nov; 64(21):7886-92. PubMed ID: 15520195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity.
    Bachmeier BE; Nerlich AG; Lichtinghagen R; Sommerhoff CP
    Anticancer Res; 2001; 21(6A):3821-8. PubMed ID: 11911253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.